Evidence map›Paper›PMID 31769957›Full record

ArticleACS chemical biology2019

Fitness Factors for Bioorthogonal Chemical Probes.

Yulin Tian, Qing Lin

Abstract read
In one paragraph

Article in ACS chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Protein Modification via Bioorthogonal HS-BCN Ligation.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Fluorogenic Cyclopropenones for Multicomponent, Real-Time Imaging.Journal of the American Chemical Society · 2022
    Article
  10. Article
  11. Article
  12. Bioorthogonal Hydroamination of Push-Pull-Activated Linear Alkynes.Angewandte Chemie (International ed. in English) · 2021
    Article
  13. Article
  14. Bioorthogonal chemistry.Nature reviews. Methods primers · 2021
    Article
  15. Covalent labeling of nucleic acids.Chemical Society reviews · 2020
    Review
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yulin TianDepartment of Chemistry , State University of New York at Buffalo , Buffalo , New York 14260-3000 , United States.
Qing LinDepartment of Chemistry , State University of New York at Buffalo , Buffalo , New York 14260-3000 , United States.ORCID 0000-0002-9196-5718

Funding

Development and Applications of Bioorthogonal Chemistry: Equipment SupplementR35GM130307 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Qing Lin · 2019 to 2026
$3.6M
Development and Applications of Photoinducible Bioorthogonal ChemistryR01GM085092 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI LIN, QING · 2009 to 2017
$2.8M
NIGMS NIH HHS R01 GM085092NIGMS NIH HHS R35 GM130307
6 · The paper itself

Abstract

Bioorthogonal chemistry has offered an invaluable reactivity-based tool to chemical biology owing to its exquisite specificity in tagging a diverse set of biomolecules in their native environment. Despite tremendous progress in the field over the past decade, designing a suitable bioorthogonal chemical probe to investigate a given biological system remains a challenge. In this Perspective, we put forward a series of fitness factors that can be used to assess the performance of bioorthogonal chemical probes. The consideration of these criteria should encourage continuous innovation in bioorthogonal probe development as well as enhance the quality of biological data.

Indexed as

Cell Membrane PermeabilityLipidsMolecular ProbesMolecular WeightSolubilityWaterLipidsMolecular ProbesWater

Identifiers

PMID31769957
PMCPMC7643054

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.